Condition: Acute Spinal Cord Injury · Sponsor: Pharmazz, Inc.
This was a prospective, multicentric, randomized, double blind, parallel, saline controlled Phase II clinical study to compare the safety and efficacy of PMZ-1620 (INN: Sovateltide) therapy along with standard supportive care in patients of acute spinal cord injury.
This description comes directly from the study's public registry record.
Manish S Lavhale · +91 9873847397 · manish.lavhale@pharmazz.com
Ravi Kant · ravi.kant@pharmazz.com
Always discuss trial participation with your own doctor first.
| KLE's Dr. Prabhakar Kore Hospital & Medical Research Centre | Belagavi, India | Not Yet Recruiting |
| Institute of Postgraduate Medical Education & Research and SSKM Hospital | Kolkata, India | Recruiting |
| King George's Medical University | Lucknow, India | Recruiting |
| Rahate Surgical Hospital & ICU | Nagpur, India | Recruiting |
| Indian Spinal Injury Centre | New Delhi, India | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04054414